Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia
- PMID: 36704147
- PMCID: PMC9871544
- DOI: 10.3389/fped.2022.1062900
Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia
Abstract
Glanzmann thrombasthenia (GT) is a rare inherited disease characterized by mucocutaneous bleeding due to the abnormalities in quantity or quality of platelet membrane GP IIb (CD41) or GP IIIa (CD61). GP IIb and GP IIIa are encoded by the ITGA2B and ITGB3 genes, respectively. Herein, we described a 7-year-old Chinese boy of the consanguineous couple who was diagnosed with GT based on the typical clinical manifestations, absence of blood clot retraction and the reduced expression of CD41 and CD61 in platelets. A homozygous silent variant c.1431C > T (p. G477=) of the ITGB3 gene was identified by the Whole-exome sequencing and confirmed by Sanger sequencing. The variant was predicted to affect the splicing. RT-PCR and sequencing revealed that the variant caused a deletion of 95 base pairs and frameshift, and subsequently created a premature stop codon in exon 10 of ITGB3 (p. G477Afs*30). It was indicated that the variant c.1431C > T (p. G477=) of ITGB3 was the cause for Glanzmann thrombasthenia. Our findings expanded the mutation spectrum and provided the information for the genetic counseling, prenatal diagnosis and preimplantation genetic testing (PGT).
Keywords: Glanzmann thrombasthenia; ITGB3; integrin αIIbβ3; silent mutation; whole exome sequencing.
© 2023 Wang, Xu, Sun, Wang and Dong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Novel homozygous frameshift mutation of ITGB3 in the Glanzmann thrombasthenia patient with abnormal bone metabolism and congenital bone defects.Orphanet J Rare Dis. 2025 Apr 18;20(1):189. doi: 10.1186/s13023-025-03700-9. Orphanet J Rare Dis. 2025. PMID: 40251671 Free PMC article.
-
Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.Thromb Haemost. 2015 Apr;113(4):782-91. doi: 10.1160/TH14-05-0479. Epub 2014 Nov 6. Thromb Haemost. 2015. PMID: 25373348
-
Management of a twin pregnancy patient with Glanzmann thrombasthenia might be caused by a novel ITGA2B gene mutation (c.2822G>A): a case report and family investigation.Platelets. 2025 Dec;36(1):2470758. doi: 10.1080/09537104.2025.2470758. Epub 2025 Mar 24. Platelets. 2025. PMID: 40126091
-
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.Expert Rev Hematol. 2012 Oct;5(5):487-503. doi: 10.1586/ehm.12.46. Expert Rev Hematol. 2012. PMID: 23146053 Review.
-
Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.J Blood Med. 2021 Jun 11;12:449-463. doi: 10.2147/JBM.S271744. eCollection 2021. J Blood Med. 2021. PMID: 34149292 Free PMC article. Review.
Cited by
-
Synonymous Variants of Uncertain Silence.Int J Mol Sci. 2023 Jun 23;24(13):10556. doi: 10.3390/ijms241310556. Int J Mol Sci. 2023. PMID: 37445732 Free PMC article.
-
Epidemiological and clinical characteristics of children and young adults with Glanzmann's thrombasthenia in upper Egypt: a multicenter cross-sectional study.Ann Hematol. 2025 Mar;104(3):1961-1973. doi: 10.1007/s00277-025-06290-5. Epub 2025 Mar 13. Ann Hematol. 2025. PMID: 40074839 Free PMC article.
References
-
- Bacci M, Ferretti A, Marchetti M, Alberelli MA, Falanga A, Lodigiani C, et al. Autoimmune disorders of platelet function: systematic review of cases of acquired glanzmann thrombasthenia and acquired delta storage pool disease. Blood Transfus. (2022) 20(5):420–32. 10.2450/2021.0119-21 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous